{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:08:37Z","timestamp":1776092917866,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKANHI","award":["19K07427"],"award-info":[{"award-number":["19K07427"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10014-025-00514-2","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:34:40Z","timestamp":1756877680000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emergence of NEC features in corticotroph PitNETs: primary tumor, radiation-induced transformation, or metastasis?"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5459-3388","authenticated-orcid":false,"given":"Naoko","family":"Inoshita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Tatsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotetsu","family":"Kanamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"514_CR1","unstructured":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Endocrine and Neuroendocrine Tumours. 5th ed. Lyon: IARC; 2022"},{"issue":"4","key":"514_CR2","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, Danskin C, Delellis RA, Earls P et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer. 24(4):C5\u2013C8. https:\/\/doi.org\/10.1530\/ERC-17-0004","journal-title":"Endocr Relat Cancer."},{"key":"514_CR3","unstructured":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Tumours of Endocrine Organs. 4th ed. Lyon: IARC; 2017"},{"issue":"11","key":"514_CR4","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1530\/JME-12-0113","volume":"103","author":"O Mete","year":"2018","unstructured":"Mete O, Ezzat S, Asa SL (2018) Biomarkers of aggressive pituitary adenomas. J Clin Endocrinol Metab. 103(11):3874\u20133884. https:\/\/doi.org\/10.1530\/JME-12-0113","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"514_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12022-020-09632-4","volume":"31","author":"M Pease","year":"2020","unstructured":"Pease M, Ling C, Mackenzie-Feder J, Perry A, Mete O, Ezzat S et al (2020) TERT promoter mutations and ATRX loss in pituitary neuroendocrine tumors. Endocr Pathol. 31(2):136\u2013144. https:\/\/doi.org\/10.1007\/s12022-020-09632-4","journal-title":"Endocr Pathol."},{"issue":"1","key":"514_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA et al (2022) Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 33(1):115\u2013154. https:\/\/doi.org\/10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol."},{"issue":"4","key":"514_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12022-024-09835-y","volume":"35","author":"NM Joseph","year":"2024","unstructured":"Joseph NM, Umetsu SE, Kim GE, Tanas MR, O\u2019Donnell R, Gill AJ et al (2024) Progression of low-grade neuroendocrine tumors (NET) to high-grade neoplasms harboring the NEC-like co-alteration of RB1 and TP53. Endocr Pathol. 35(4):325\u2013337. https:\/\/doi.org\/10.1007\/s12022-024-09835-y","journal-title":"Endocr Pathol."},{"issue":"4","key":"514_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12022-024-09827-y","volume":"35","author":"A Kasajima","year":"2024","unstructured":"Kasajima A, Pfarr N, Mayr EM, Ura A, Moser E, von Werder A et al (2024) Rapid evolution of metastases in patients with treated G3 neuroendocrine tumors associated with NEC-like transformation and TP53 mutation. Endocr Pathol 35(4):313\u2013324. https:\/\/doi.org\/10.1007\/s12022-024-09827-y","journal-title":"Endocr Pathol"},{"issue":"5","key":"514_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00428-024-04006-0","volume":"486","author":"C Kanaan","year":"2025","unstructured":"Kanaan C, Bani MA, Ducreux M, Planchard D, Lamartina L, Moog S, Pudlarz T, Baudin E, Hadoux J, Al-Ghuzlan A, Scoazec JY (2025) Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms. Virchows Arch 486(5):941\u2013950. https:\/\/doi.org\/10.1007\/s00428-024-04006-0","journal-title":"Virchows Arch"},{"key":"514_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2213-8587(22)00160-7","volume":"10","author":"R Hamblin","year":"2022","unstructured":"Hamblin R, Vardon A, Akpalu J, Tampourlou M, Spiliotis I, Sbardella E et al (2022) Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. Lancet Diabetes Endocrinol 10:581\u201388. https:\/\/doi.org\/10.1016\/S2213-8587(22)00160-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"514_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.radonc.2009.09.011","volume":"93","author":"SC Erridge","year":"2009","unstructured":"Erridge SC, Conkey DS, Stockton D, Grant R, Kerr GR, Gregor A (2009) Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiother Oncol 93(3):597\u2013601. https:\/\/doi.org\/10.1016\/j.radonc.2009.09.011","journal-title":"Radiother Oncol"},{"issue":"3","key":"514_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1210\/jc.2018-01524","volume":"104","author":"M Ammar","year":"2019","unstructured":"Ammar M, Coopmans EC, Gatto F, Franck SE, Janssen JAMJL, van der Lely AJ et al (2019) Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression. J Clin Endocrinol Metab. 104(3):915\u2013924. https:\/\/doi.org\/10.1210\/jc.2018-01524","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"514_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11102-017-0791-0","volume":"20","author":"MR Gadelha","year":"2017","unstructured":"Gadelha MR, Wildemberg LE, Bronstein MD, Gatto F, Ferone D (2017) Somatostatin receptor ligands in the treatment of acromegaly. Pituitary 20(1):100\u2013108. https:\/\/doi.org\/10.1007\/s11102-017-0791-0","journal-title":"Pituitary"},{"issue":"4","key":"514_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A et al (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26(4):349\u2013355. https:\/\/doi.org\/10.1007\/s12022-015-9398-z","journal-title":"Endocr Pathol"},{"issue":"3","key":"514_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10014-023-00442-2","volume":"40","author":"N Inoshita","year":"2023","unstructured":"Inoshita N, Yoshimoto T, Takazawa Y, Noriaki F, Mitsuo O, Hiroshi N, Shozo Y (2023) Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs. Brain Tumor Pathol. 40(3):158\u2013162. https:\/\/doi.org\/10.1007\/s10014-023-00442-2","journal-title":"Brain Tumor Pathol."}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-025-00514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-025-00514-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-025-00514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:18:52Z","timestamp":1776089932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-025-00514-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1007\/s10014-025-00514-2","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This case report is part of a study approved by the institutional ethics committee of Toranomon Hospital (approval number: 2536).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written comprehensive informed consent for the use of clinical data and pathological materials in research and publication was obtained from both patients prior to death, in accordance with the institutional policy for pituitary surgery.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}